UXS1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.95341529010784E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.87880000002139E-07 |
Normal-vs-Stage2 |
2.797800E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.120600E-03 |
Stage1-vs-Stage2 |
3.435000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.676200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.540200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.71369585189041E-11 |
Normal-vs-AfricanAmerican |
1.770650E-01 |
Normal-vs-Asian |
3.354300E-02 |
Caucasian-vs-AfricanAmerican |
2.659700E-03 |
Caucasian-vs-Asian |
5.468200E-01 |
AfricanAmerican-vs-Asian |
1.414390E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.39590000003409E-06 |
Normal-vs-Female |
1.17759999973543E-07 |
Male-vs-Female |
2.422800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.999770E-03 |
Normal-vs-Extreme_Weight |
5.71880000022063E-07 |
Normal-vs-Obese |
2.523500E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.058200E-01 |
Normal_Weight-vs-Obese |
4.481000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.251200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.232020E-01 |
Normal-vs-Age(41-60Yrs) |
1.614560E-04 |
Normal-vs-Age(61-80Yrs) |
5.68119999933003E-08 |
Normal-vs-Age(81-100Yrs) |
2.660600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.657600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.129200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.160600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.614200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.535000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.240000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
2.847200E-01 |
Normal-vs-Grade 3 |
2.162200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.030400E-01 |
Grade 2-vs-Grade 4 |
2.847200E-01 |
Grade 3-vs-Grade 4 |
2.162200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.88669996187474E-09 |
Normal-vs-N1 |
1.069760E-02 |
N0-vs-N1 |
9.189600E-01 |
|
|